Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is a significant contributor to cancer-related morbidity and mortality, and it is known for its resistance to conventional treatment regimens, including chemotherapy and immune checkpoint blockade (ICB)-based therapies. We have previously shown that Urolithin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehra, Siddharth, Garrido, Vanessa T., Dosch, Austin R., Lamichhane, Purushottam, Srinivasan, Supriya, Singh, Samara P., Zhou, Zhiqun, De Castro Silva, Iago, Joshi, Chandrashekar, Ban, Yuguang, Datta, Jashodeep, Gilboa, Eli, Merchant, Nipun B., Nagathihalli, Nagaraj S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337606/
https://www.ncbi.nlm.nih.gov/pubmed/37448553
http://dx.doi.org/10.1158/2767-9764.CRC-22-0329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337606/
https://www.ncbi.nlm.nih.gov/pubmed/37448553
http://dx.doi.org/10.1158/2767-9764.CRC-22-0329

Ejemplares similares